Welcome to our latest issue of EMJ Rheumatology, which includes a selection of original articles alongside a review the EULAR 2022 Congress with key highlights from the event. Featured articles include a review of metabolic syndrome and its outcomes in rheumatoid arthritis, and an article summarising the functions and regulations of Type I interferons in the pathogenesis of Sjögren’s syndrome.
Latest articlesAll articles
Infographic: Osteoarthritis - Redefining the Way We Consider This Chronic Condition
Osteoarthritis is the most common form of long-term musculoskeletal disease, and is increasing in prevalence as societies become older. One of the key factors of living well with a disease that spans decades of a patient’s life is to diagnose the condition earlier, long before the disease limits function significantly, or causes disability.
Tackling Unmet Medical Need: How Slow-Release Intra-articular Corticosteroids Could Play a Role in Improving Quality of Life and Reducing Risk in Osteoarthritis
Osteoarthritis (OA) is the fastest growing cause of disability worldwide, but, with few proven therapeutic options, it is an underserved condition. With increasingly ageing populations contributing to a rising global prevalence, this unmet need only threatens to worsen in the coming years.
Immune Relevant Behavioural Interventions: Immunological Evidence as an Integral Measure of Behavioural Interventions for Rheumatic Diseases, a Review of Current Research
Behavioural interventions and immunologic indicators of health, disease activity, and immune function are discrete subject areas